2012


To access this material please log in or register

Register Authorize
2012/№3

Immediate and remote results of surgical treatment in patients with aortal defects complicated by left ventricle systolic dysfunction

Mekhtiev E. K., Semenovsky M. L., Poptsov V. N., Chestukhin V. V., Vavilov P. A., Ostroumov E. N., Aniskevich G. V.

Keywords: aortal valve, systolic dysfunction of the left ventricle, surgical therapy

DOI: 10.18087 / rhfj.2012.3.1666

Relevance. Surgical treatment of severe senior patients with defects of aortal valve and LV dysfunction, presence of combined IHD, other concomitant pathology, is a difficult task due to high risk of lethal outcome. Objective. To conduct and to present results of analysis of immediate and remote results of surgical treatment of patients with aortal defects complicated by severe systolic dysf unction (LV EF<35 %). Materials and methods. The analysis of immediate and remote surgical therapy results of patients with aortal defects and intense LV systolic dysf unction (EF lower than 35 %) in he period from January 2005 to July 2011. The study included 44 patients to whom correction of aortal defect was done. In order to improve surgery results we have been used a targeted protocol of pre and post surgery care. This protocol regulates the preventive preparation in the intensive care unit with application of Levosimendan, kidney replacement therapy in the post-operative period and usage of the hybrid approach in patients who have a combination of valvular disease with IHD. Results. Hospital mortality rate made 4.5 %. Survival rate in 1, 3 and 5 years made 92.7, 89.5 and 71.2 %, respectively. Conclusion. Surgical therapy of patients with aortal defects, complicated by expressed LV systolic dysfunction is the only effective method allowing obtaining encouraging results at low level of hospital mortality rate, spurred by the protocol of the perioperational maintenance of this especially severe category of patients.
  1. Rothenburger M, Drebber K, Tjan TD et al. Aortic valve replacement for aortic regurgitation and stenosis, in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2003;23 (5):703–709.
  2. Pomerantz BJ, Wollmuth JR, Krock MD et. al. Myocardial systolic strain is decreased after aortic valve replacement in patients with aortic insufficiency. Ann Thorac Surg. 2005;80 (6):2186–2192.
  3. Collinson J, Henein M, Flather M et al. Valve replacement for aortic stenosis in patients with poor left ventricular function: comparison of early changes with stented and stentless valves. Circulation. 1999;100 (19 Suppl): II1–5.
  4. Chukwuemeka A, Rao V, Armstrong S et al. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. Eur J Cardiothorac Surg. 2006;29 (2):133–138.
  5. Turk R, Varadarajan P, Kamath A et al. Survival benefit of aortic valve replacement on older patients with asymptomic chronic severe aortic regurgitation. Ann Thorac Surg. 2010;89 (3):731–737.
  6. Connolly HM, Oh JK, Schaff HV et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation. 2000;101 (16):1940–1946.
  7. Tarantini G, Buja P, Scognamiglio R et al. Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery. Eur J Cardiothorac Surg. 2003;24 (6):879–885.
  8. Джангулян Н. Г. Эффективность хирургической коррекции аортального стеноза в группе пациентов с низкой сократительной способностью миокарда. Врач-аспирант 2005;2:151–156. Доступно на: http://ska4ay.ru / ?action=showfullscreen&id=4234.
  9. Levy F, Laurent M, Monin JL et al. Aortic valve replacement for low-flow / low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol. 2008;51 (15):1466–1472.
  10. Ding WH, Lam YY, Duncan A et al. Predictors of survival after aortic valve replacement in patients with low-flow and high-gradient aortic stenosis. Eur J Heart Fail. 2009;11 (9):897–902.
  11. Halkos ME, Chen EP, Sarin EL et al. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. Ann Thorac Surg. 2009;88 (3):746–751.
  12. Шматов Д. В., С. И. Железнев, Д. А. Астапов и др. Непосредственные результаты протезирование аортального клапана у пациентов с аортальным стенозом и систолической дисфункцией левого желудочка. Патология кровообращения и кардиохирургия. 2010;4:24–28.
  13. Шевченко Ю. Л., Попов Л. В., Кучеренко В. С. и др. Функциональная митральная недостаточность у больных стенозом устья аорты. Вестник Национального медико-хирургического центра им. Н. И. Пирогова. 2011;6 (1):12–15.
  14. Borowski A, Ghodsizad A, Vchivkov I, Gams E. Surgery for severe aortic stenosis with low transvalvular gradient and poor left ventricular function – single centre experience and review of the literature. J Cardiothorac Surg. 2007 Jan 31;2:9.
  15. Hoefer D, Jonetzko P, Hoermann C et al. Successful administration of levosimendan in a patient with low-gradient low-output aortic stenosis. Wien Klin Wochenschr. 2006;118 (1-2):60–2.
  16. McCarthy PM. Aortic valve surgery in patients with left ventricular dysfunction. Semin Thorac Cardiovasc Surg. 2002;14 (2):137–143.
  17. Thompson R, Yacoub M, Ahmed M et al. Influence of preoperative left ventricular function on results of homograft replacement of the aortic valve for aortic stenosis. Am J Cardiol. 1979;43 (5):929–938.
  18. Rediker DE, Boucher CA, Block PC et al. Degree of reversibility of left ventricular dysfunction aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol. 1987;60 (1):112–118.
  19. Brogan WC 3rd, Grayburn PA, Lange RA, Hillis LD. Prognosis after valve replacement in patients with severe aortic stenosis and a low transvalvular pressure gradient. J Am Coll Cardiol. 1993;21 (7):1657–1660.
  20. Chaliki HP, Mohty D, Avierinos JF et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation. 2002;106 (21):2687–2693.
  21. Powell DE, Tunick PA, Rosenzweig BP et al. Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch Intern Med. 2000;160 (9):1337–1341.
  22. Sharony R, Grossi EA, Saunders PC et al. Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg. 2003;75 (6):1808–1814.
  23. Vaquette B, Corbineau H, Laurent M et al. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome. Heart. 2005;91 (10):1324–1329.
  24. Bevilacqua S, Gianetti J, Ripoli A et al. Aortic valve disease with severe ventricular dysfunction: stentless valve for better recovery. Ann Thorac Surg. 2002;74 (6):2016–2021.
  25. Nieminen M, Akkila J, Hasenfuss G et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol. 2000;36 (6):1903–1912.
  26. Slawsky MT, Colucci WS, Gottlieb SS et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation. 2000;102 (18):2222–2227.
  27. Follath F, Cleland JG, Just H et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360 (9328):196–202.
  28. Labriola C, Siro-Brigiani M, Carrata F et al. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther. 2004;42 (4):204–211.
  29. Tasouli A, Papadopoulos K, Antoniou T et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg. 2007;32 (4):629–633.
  30. Kobayashi KJ, Williams JA, Nwakanma L et al. Aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts. Ann Thorac Surg. 2007;83 (3):969–978.
  31. Shahian DM, O’Brien SM, Filardo G et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88 (1 Suppl): S43–62.
  32. Gunay R, Sensoz Y, Kayacioglu I et al. Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery? Interact Cardiovasc Thorac Surg. 2009;9 (4):630–634.
  33. Бокерия Л. А., Газал Белал. Результаты одномоментного протезирования аортального клапана и шунтирования коронарных артерий: предикторы летальных исходов. Грудная и сердечно-сосудистая хирургия. 2009;5:21–26.
  34. Byrne JG, Leacche M, Vaughan DE, Zhao DX. Hybrid cardiovascular procedures. JACC Cardiovasc Interv. 2008;1 (5):459–468.
  35. Семеновский М. Л., Вавилов П. А., Миронков Б. Л. и др. Гибридный метод лечения сочетанной патологии (пороки сердца и ишемическая болезнь сердца) у больных старше 70 лет. Журнал Груд. и сердечно-сосудистая хирургия. 2010;3:8–12.
  36. Ruel M, Kapila V, Price J et al. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114 (1 Suppl): I541–546.
  37. Vanden Eynden F, Bouchard D, El-Hamamsy I et al. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Ann Thorac Surg. 2007;83 (4):1279–1284.
  38. Moazami N, Diodato MD, Moon MR et al. Does functional mitral regurgitation improve with isolated aortic valve replacement? J Card Surg. 2004;19 (5):444–448.
  39. Caballero-Borrego J, Gómez-Doblas JJ, Cabrera-Bueno F et al. Incidence, associated factors and evolution of non-severe functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement. Eur J Cardiothorac Surg. 2008;34 (1):62–66.
  40. Скопин И. И., Цискаридзе И. М., Сливнева И. В. и др. Предикторы послеоперационных осложнений и госпитальной летальности у пациентов с аортальными пороками и сопутствующей митральной недостаточностью. Грудная и сердечно-сосудистая хирургия. 2010;2:18–24.
  41. Waisbren EC, Stevens LM, Avery EG et al. Changes in mitral regurgitation after replacement of the stenotic aortic valve. Ann Thorac Surg. 2008;86 (1):56–62.
  42. McCarthy PM, Bhudia SK, Rajeswaran J et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127 (3):674–685.
  43. Fukuda S, Song JM, Gillinov AM et al. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation. 2005;111 (8):975–979.
  44. Семеновский М. Л, Бричков М. Л. Трехклапанное протезирование (старые проблемы, новые перспективы). Грудная и сердечно-сосудистая хирургия. 1992;13–14:7–11.
  45. Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg. 1998;66 (6):1940–1947.
  46. Козлов И. А., Пиляева И. Е., Маркин С. М. и др. Раннее прекращение искусственной вентиляции легких у больных, оперированных с искусственным кровообращением. Анестезиология и реаниматология. 1995;3:27–31.
  47. Blais C, Dumesnil JG, Baillot R et al. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation. 2003;108 (8):983–988.
Mekhtiev E. K., Semenovsky M. L., Poptsov V. N. et al. Immediate and remote results of surgical treatment in patients with aortal defects complicated by left ventricle systolic dysfunction. Russian Heart Failure Journal. 2012;13(3):151-157

To access this material please log in or register

Register Authorize
Ru En